Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
Intensive Hospital-based Adverse Drug Reaction Monitoring Study On Patients Treated By Qingkailing Injection In The Next Two Years
1 other identifier
observational
30,840
1 country
48
Brief Summary
To highlight the incidence of adverse reactions of Qingkailing Injection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
48 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 7, 2013
CompletedFirst Posted
Study publicly available on registry
January 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFebruary 19, 2018
February 1, 2018
4.9 years
January 7, 2013
February 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of severe adverse drug reactions
2 years
Secondary Outcomes (1)
incidence of adverse drug reactions
2 years
Study Arms (1)
Qingkailing Injection
Interventions
Qingkailing Injection is a kind of natural product injection made from Chinese herbs, which has been used to treat cerebral ischemia for decades in China. The main bioactive ingredients of this injection include Baicalin, Jasminoidin, Ursodeoxycholic Acid, Concha Margaritifera,etc.
Eligibility Criteria
all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
You may qualify if:
- all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
- in accordance with ethics requirements.
You may not qualify if:
- none.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (48)
National Defense University Hospital of People's Liberation Army
Beijing, Beijing Municipality, 100094, China
Ren'ai Hospital
Shenzhen, Guangdong, 518000, China
Chinese Medicine Hospital of Deqing County
Zhaoqing, Guangdong, 526600, China
Chinese Medicine Hospital of Gaoyang County
Baoding, Hebei, 071599, China
Gaoyang County Hospital
Baoding, Hebei, 071599, China
The Third People's Hospital of Xiong County
Baoding, Hebei, 071802, China
Chinese Medicine Hospital of Xiong County
Baoding, Hebei, 071899, China
Chinese Medicine Hospital of Tang County
Baoding, Hebei, 072350, China
People's Hospital of Tang County
Baoding, Hebei, 072350, China
Chinese Medicine Hospital of Handan City
Handan, Hebei, 056001, China
The First Hospital of Yongnian District
Handan, Hebei, 057150, China
The Second Hospital of Yongnian District
Handan, Hebei, 057150, China
Central Hospital of Shijiazhuang City
Shijiazhuang, Hebei, 050011, China
Hebei Chest Hospital
Shijiazhuang, Hebei, 050041, China
Chinese Medicine Hospital of Shijiazhuang City
Shijiazhuang, Hebei, 050061, China
Central Hospital of Qinghe County
Xingtai, Hebei, 054000, China
Chinese Medicine Hospital of Xingtai City
Xingtai, Hebei, 054001, China
Eye Hospital of Xingtai City
Xingtai, Hebei, 054001, China
The Second Affiliated Hospital of Xingtai Medical College
Xingtai, Hebei, 054099, China
Chinese Medicine Hospital of Qinghe County
Xingtai, Hebei, 054800, China
The Second Hospital of Bayan County
Harbin, Heilongjiang, 151801, China
Luohe Hospital of Chinese Medicine
Luohe, Henan, 462099, China
Central Hospital of Sanmenxia City
Sanmenxia, Henan, 472000, China
People's Hospital of Shan County
Sanmenxia, Henan, 472100, China
The First People's Hospital of Lingbao
Sanmenxia, Henan, 472500, China
Chinese Medicine Hospital of Xinxiang City
Xinxiang, Henan, 453003, China
The Third Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, 453003, China
People's Hospital of Yanjin County
Xinxiang, Henan, 453200, China
Chinese Medicine Hospital of Fengqiu County
Xinxiang, Henan, 453300, China
People's Hospital of Fengqiu County
Xinxiang, Henan, 453399, China
People's Hospital of Yuanyang County
Xinxiang, Henan, 453500, China
People's Hospital of Xinzheng City
Xinzheng, Henan, 451100, China
Third Affiliated Hospital of Henan College of Traditional Chinese Medicine
Zhengzhou, Henan, 450008, China
Chinese Medicine Hospital of Xinzheng
Zhengzhou, Henan, 451199, China
Affiliated Zhongshan Hospital of Dalian University
Dalian, Liaoning, 116001, China
Central Hospital of Liaocheng City
Liaocheng, Shandong, 252001, China
Veterans'Hospital
Liaocheng, Shandong, 252003, China
Chinese Medicine Hospital of Dongchangfu District
Liaocheng, Shandong, 252027, China
Chinese Medicine Hospital of Chiping County
Liaocheng, Shandong, 252100, China
YangGuXian People's Hospital
Liaocheng, Shandong, 252300, China
Chinese Medicine Hospital of Linqing
Liaocheng, Shandong, 252661, China
Chinese Medicine Hospital of Gaotang County
Liaocheng, Shandong, 252800, China
Community Health Center of Duqiao
Weinan, Shanxi, China
Chinese Medicine Hospital of Sanyuan County
Xianyang, Shanxi, 713800, China
People's Hospital of Fuyuan County
Qujing, Yunnan, 655500, China
Chinese Medicine Hospital of Luliang County
Qujing, Yunnan, 655600, China
People's Hospital of Luliang County
Qujing, Yunnan, 655600, China
Chinse Medical Hospital of Shizong County
Qujing, Yunnan, 655700, China
Related Publications (1)
Yao Q, Wei T, Qiu H, Cai Y, Yuan L, Liu X, Li X. Epigenetic Effects of Natural Products in Inflammatory Diseases: Recent Findings. Phytother Res. 2025 Jan;39(1):90-137. doi: 10.1002/ptr.8364. Epub 2024 Nov 8.
PMID: 39513382DERIVED
Biospecimen
whole blood of the patient with severe adverse drug reactions
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhong Wang, Ph.D., M.D.
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 7, 2013
First Posted
January 9, 2013
Study Start
January 1, 2013
Primary Completion
December 1, 2017
Study Completion
January 1, 2018
Last Updated
February 19, 2018
Record last verified: 2018-02